These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1634 related items for PubMed ID: 11329528

  • 21. Diagnosis and management of diastolic dysfunction and heart failure.
    Satpathy C, Mishra TK, Satpathy R, Satpathy HK, Barone E.
    Am Fam Physician; 2006 Mar 01; 73(5):841-6. PubMed ID: 16529092
    [Abstract] [Full Text] [Related]

  • 22. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 01; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 23. Treatment of congestive heart failure in older persons.
    Aronow WS.
    J Am Geriatr Soc; 1997 Oct 01; 45(10):1252-7. PubMed ID: 9329490
    [Abstract] [Full Text] [Related]

  • 24. Use of digoxin, diuretics, beta blockers, angiotensin-converting enzyme inhibitors, and calcium channel blockers in older patients in an academic hospital-based geriatrics practice.
    Fishkind D, Paris BE, Aronow WS.
    J Am Geriatr Soc; 1997 Jul 01; 45(7):809-12. PubMed ID: 9215330
    [Abstract] [Full Text] [Related]

  • 25. Heart failure due to left ventricular systolic dysfunction: treatment at discharge from hospital and at one year.
    Houpe D, Peltier M, Cohen-Solal A, Béguin M, Lévy F, Slama M, Chapelain K, Tribouilloy C.
    Int J Cardiol; 2005 Sep 01; 103(3):286-92. PubMed ID: 16098391
    [Abstract] [Full Text] [Related]

  • 26. Optimization of heart FailUre medical Treatment after hospital discharge according to left ventricUlaR Ejection fraction: the FUTURE survey.
    Cohen Solal A, Leurs I, Assyag P, Beauvais F, Clerson P, Contre C, Thebaut JF, Genoun M, French National College of Cardiologists.
    Arch Cardiovasc Dis; 2012 Sep 01; 105(6-7):355-65. PubMed ID: 22800720
    [Abstract] [Full Text] [Related]

  • 27. From left ventricular dysfunction to heart failure.
    Cleland JG.
    Arch Mal Coeur Vaiss; 1996 Nov 01; 89(11):1397-402. PubMed ID: 9092398
    [Abstract] [Full Text] [Related]

  • 28. Mechanistic and clinical rationales for using beta-blockers in heart failure.
    Bristow MR.
    J Card Fail; 2000 Jun 01; 6(2 Suppl 1):8-14. PubMed ID: 10908093
    [Abstract] [Full Text] [Related]

  • 29. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction.
    Sander GE, McKinnie JJ, Greenberg SS, Giles TD.
    Prog Cardiovasc Dis; 1999 Jun 01; 41(4):265-300. PubMed ID: 10362349
    [Abstract] [Full Text] [Related]

  • 30. [The use of beta blockers in heart failure: clinical studies].
    Cobelli F.
    Ital Heart J Suppl; 2000 Aug 01; 1(8):996-1002. PubMed ID: 10993005
    [Abstract] [Full Text] [Related]

  • 31. Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis.
    Verdecchia P, Angeli F, Cavallini C, Gattobigio R, Gentile G, Staessen JA, Reboldi G.
    Eur Heart J; 2009 Mar 01; 30(6):679-88. PubMed ID: 19168534
    [Abstract] [Full Text] [Related]

  • 32. [Diastolic heart failure].
    Smulders YM, Stehouwer CD, Bronzwaer JG, Kamp O.
    Ned Tijdschr Geneeskd; 2003 Dec 13; 147(50):2467-70. PubMed ID: 14708211
    [Abstract] [Full Text] [Related]

  • 33. Congestive heart failure: what should be the initial therapy and why?
    Chatterjee K.
    Am J Cardiovasc Drugs; 2002 Dec 13; 2(1):1-6. PubMed ID: 14727993
    [Abstract] [Full Text] [Related]

  • 34. Guideline for the management of heart failure caused by systolic dysfunction: part II. Treatment.
    Chavey WE, Blaum CS, Bleske BE, Harrison RV, Kesterson S, Nicklas JM, American Heart Association.
    Am Fam Physician; 2001 Sep 15; 64(6):1045-54. PubMed ID: 11578026
    [Abstract] [Full Text] [Related]

  • 35. Medical management of mild-to-moderate heart failure before the advent of beta blockers.
    Abraham WT, Wagoner LE.
    Am J Med; 2001 May 07; 110 Suppl 7A():47S-62S. PubMed ID: 11334776
    [Abstract] [Full Text] [Related]

  • 36. Patterns of physician use of angiotensin converting enzyme inhibitors in the inpatient treatment of congestive heart failure.
    Ghali JK, Giles T, Gonzales M, Horswell R, Kumar S, Lejuene A, Livaudais GF, Sarkar IC.
    J La State Med Soc; 1997 Dec 07; 149(12):474-84. PubMed ID: 9425858
    [Abstract] [Full Text] [Related]

  • 37. A hard look at angiotensin receptor blockers in heart failure.
    Gring CN, Francis GS.
    J Am Coll Cardiol; 2004 Nov 02; 44(9):1841-6. PubMed ID: 15519017
    [Abstract] [Full Text] [Related]

  • 38. Contemporary medical management of left ventricular dysfunction and congestive heart failure.
    Teo KK, Ignaszewski AP, Gutierrez R, Hill KL, Martin SL, Calhoun HP, Humen DP, Montague TJ.
    Can J Cardiol; 1992 Nov 02; 8(6):611-9. PubMed ID: 1354569
    [Abstract] [Full Text] [Related]

  • 39. Prescription patterns of pharmacological agents for left ventricular systolic dysfunction among hemodialysis patients.
    Roy P, Bouchard J, Amyot R, Madore F.
    Am J Kidney Dis; 2006 Oct 02; 48(4):645-51. PubMed ID: 16997061
    [Abstract] [Full Text] [Related]

  • 40. Pharmacologic management of heart failure caused by systolic dysfunction.
    Chavey WE, Bleske BE, Van Harrison R, Hogikyan RV, Kesterson SK, Nicklas JM.
    Am Fam Physician; 2008 Apr 01; 77(7):957-64. PubMed ID: 18441861
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 82.